EUS与MRCP在特发性急性胰腺炎中的比较:系统评价与Meta分析
该系统评价与Meta分析检索多个数据库至2017年4月,纳入34项研究(n=2338),其中7项研究同时使用EUS和MRCP(共249例患者)。结果显示EUS组诊断率64%(153/239)高于MRCP组34%(82/238)(P<.001);在胰胆管解剖异常如胰腺分裂中,S-MRCP优于MRCP和EUS(12% vs 2% vs 2%)。结论认为EUS和MRCP应作为互补技术用于特发性急性胰腺炎的诊断检查。
要点
- EUS对特发性急性胰腺炎病因诊断率64%(153/239)高于MRCP的34%(82/238)(P<.001)。
- 在慢性胰腺炎和胆道疾病亚组分析中,EUS优于MRCP(P<.001)。
- 诊断胰腺分裂时S-MRCP优于MRCP和EUS(12% vs 2% vs 2%)。
核心结论
- EUS和MRCP应作为互补技术用于特发性急性胰腺炎的诊断检查。
- EUS在特发性急性胰腺炎病因诊断中准确率高于MRCP(64% vs 34%),应优先用于确定可能的胆道疾病和慢性胰腺炎诊断。
- S-MRCP在诊断胆胰管系统可能解剖异常如胰腺分裂方面优于EUS和MRCP。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、EMBASE、OVID、Cochrane Library(包括CENTRAL)、中国知网(CNKI)和万方数据库,从建库至2017年4月。
- 纳入使用EUS和/或MRCP对特发性急性胰腺炎进行病因诊断的研究。
- 共纳入34项研究(n=2338),其中7项研究同时使用EUS和MRCP,共249例患者。
主要发现
- 在7项比较EUS与MRCP的研究中,EUS组诊断率为64%(153/239),MRCP组为34%(82/238),差异有统计学意义(P<.001)。
- 诊断率在EUS组为60%,MRCP组为24%,促胰液素刺激后MRCP(S-MRCP)组为43%。
- 在慢性胰腺炎和胆道疾病的亚组分析中,EUS优于MRCP(P<.001)。
- 在诊断胰腺分裂方面,S-MRCP明显优于MRCP和EUS(12% vs 2% vs 2%)。
临床怎么用
- EUS和MRCP应作为互补技术用于特发性急性胰腺炎的诊断检查。
- EUS应优先用于确定可能的胆道疾病和慢性胰腺炎诊断。
- S-MRCP在诊断胆胰管系统可能解剖异常如胰腺分裂方面优于EUS和MRCP。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Idiopathic acute pancreatitis (IAP) poses a diagnostic challenge for gastroenterologists, because confirmation of the disease etiology has important implications for the selection of the best possible treatment and the prevention of possible recurrence or the development of chronic pancreatitis (CP). ERCP, EUS, and MRCP typically are used to diagnose IAP when conventional radiologic methods fail. However, their exact role in the diagnosis of IAP has not yet been determined. METHODS: We searched the PubMed, EMBASE, OVID, Cochrane Library (including CENTRAL), China National Knowledge Infrastructure (CNKI), and Wanfang databases from inception to April 2017. Studies involving the use of EUS and/or MRCP for the etiologic diagnosis of IAP were included. A meta-analysis was performed by using Review Manager Version 5.2 for comparative studies and R software 3.3.3 to determine diagnostic yield of the studies. RESULTS: Among the 34 studies that met the inclusion criteria (n = 2338), 7 studies used a combination of EUS and MRCP and totaled 249 patients. The results comparing EUS with MRCP showed a diagnostic yield of 153 of the 239 patients (64%) in the EUS group, which was higher than the yield of 82 of 238 patients (34%) in the MRCP group (P < .001) in the 7 studies, and the diagnostic yield was 60% in the EUS group, 24% in the MRCP group, and 43% in the MRCP after secretin stimulation (S-MRCP) group. In our subgroup analysis of CP and biliary disease, EUS was superior to MRCP (P < .001), but when comparing the efficacy of the modalities in the diagnosis of pancreatic divisum, S-MRCP was obviously superior to MRCP and EUS (12% vs 2% vs 2%). CONCLUSION: EUS and MRCP should both be used in the diagnostic work-up of IAP as complementary techniques. EUS had a higher diagnostic accuracy than MRCP (64% vs 34%) in the etiologic diagnosis of IAP and should be preferred for establishing a possible biliary disease and CP diagnosis, whereas S-MRCP was superior to EUS and MRCP in diagnosing a possible anatomic alteration in the biliopancreatic duct system, such as pancreatic divisum.
引用
- Wan J, Ouyang Y, Yu C, et al. Comparison of EUS with MRCP in idiopathic acute pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc. 2017. PMID: 29225082. doi:10.1016/j.gie.2017.11.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。